To determine whether PI3K/AKT signaling is also inhibited in cancer cells following FAM83B ablation, shRNA targeting FAM83B (B) or GFP (G) was delivered to HCC1937 and MDA468 breast cancer cells (harboring elevated EGFR). The gene discussed is AKT1; the disease is breast cancer.